|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 1.740 SEK | -7.20% |
|
+1.16% | -15.53% |
| 09-30 | Pila Pharma launches safety portion of obesity study | FW |
| 09-29 | Pila Pharma begins recruitment for obesity study | FW |
| Market Cap | 79.49M 7.92M 7.04M 6.57M 5.99M 11.29M 761M 11.4M 30.8M 389M 29.74M 29.09M 1.25B | P/E 2026 * |
-13.4x | P/E 2027 * | -7.57x |
|---|---|---|---|---|---|
| Enterprise Value | 47.49M 4.73M 4.2M 3.92M 3.58M 6.75M 455M 6.81M 18.4M 233M 17.77M 17.38M 746M | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
65.44% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| PILA | Delayed | |
Deutsche Boerse AG
| 5KC | Delayed |
Last Transcript: Pila Pharma AB
| 1 day | -7.20% | ||
| 1 week | +1.16% | ||
| Current month | -7.94% | ||
| 1 month | +2.35% | ||
| 3 months | +40.89% | ||
| 6 months | -16.55% | ||
| Current year | -15.53% |
| 1 week | 1.61 |  | 1.94 |
| 1 month | 1.4 | | 2.39 |
| Current year | 1.02 | | 2.5 |
| 1 year | 1.02 | | 2.5 |
| 3 years | 0.99 | | 9.2 |
| 5 years | 0.99 | | 9.2 |
| 10 years | 0.99 | | 12.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 33 | 2024-03-31 | |
Dorte Xenia Gram
CEO | Chief Executive Officer | 57 | 2013-12-31 |
Hampus Darrell
DFI | Director of Finance/CFO | - | 2024-12-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Dorte Xenia Gram
CHM | Chairman | 57 | 2024-03-31 |
| Director/Board Member | 59 | 2023-05-29 | |
| Director/Board Member | 54 | 2024-03-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.20% | +1.16% | -25.64% | -8.18% | 7.92M | |
| -0.61% | -3.43% | +36.07% | +115.04% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.63% | 617B | |
| +1.11% | -0.58% | +12.36% | +77.95% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.24% | 356B | |
| -0.95% | -4.05% | +20.54% | +41.71% | 333B | |
| -1.46% | -2.89% | +10.57% | +32.81% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.98% | 244B | |
| -1.04% | -2.79% | +35.30% | +51.84% | 218B | |
| -1.87% | -4.10% | +28.44% | +93.66% | 179B | |
| Average | -1.40% | -2.94% | +20.90% | +51.97% | 369.72B | |
| Weighted average by Cap. | -0.60% | -3.33% | +29.07% | +70.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -7M -698K -620K -578K -527K -994K -67.05M -1M -2.71M -34.28M -2.62M -2.56M -110M | -19M -1.89M -1.68M -1.57M -1.43M -2.7M -182M -2.72M -7.36M -93.04M -7.11M -6.95M -299M |
| Net Debt | -32M -3.19M -2.83M -2.64M -2.41M -4.55M -307M -4.59M -12.4M -157M -11.97M -11.71M -503M | -13M -1.3M -1.15M -1.07M -979K -1.85M -125M -1.86M -5.04M -63.66M -4.86M -4.76M -204M |
Employees
1
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | SEK 1.740 | -7.20% | 71,483 |
| 26-10-01 | SEK 1.875 | -0.79% | 95,907 |
| 26-09-30 | SEK 1.890 | +2.16% | 85,426 |
| 26-09-29 | SEK 1.850 | +8.19% | 78,294 |
| 26-09-28 | SEK 1.710 | -0.58% | 96,109 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PILA Stock
Select your edition
All financial news and data tailored to specific country editions
